Κακασής Αθανάσιος

Πτυχίο Ιατρικής

• Ιατρική Σχολή-Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ), (2010).

• Εσωτερική Παθολογία-Γενικό Νοσοκομείο Αθηνών «Γ. Γεννηματάς», (2019).
• Λοιμωξιολογία- Πανεπιστημιακό Γενικό Νοσοκομείο Αθηνών «Λαϊκό», (2023).

• ΜSc «Παγκόσμια Υγεία»- Ιατρική Σχολή Πανεπιστημίου Αθηνών, (2020)

• Μέλος Ελληνικής Εταιρείας Λοιμώξεων
• Μέλος European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

• Aγγλικά

Journal:                                                                                                                                             

• Kakasis A, Panitsa G. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int J Antimicrob Agents. 2019 Jan;53(1):16-21. doi: 10.1016/j.ijantimicag.2018.09.004. Epub 2018 Sep 17. PMID: 30236954

Conferences:                                                                                                                            

• Zerva, A. Karapanou, I. Deliolanis, A. Markogiannakis, F. Ntziora, A. Anastasopoulou, Ι. Pavleas, M. N. Gkamaletsou, D. Basoulis, P. M. Voutsinas, A. Kakasis, E. Mastrogianni, F. Kontopidou, M.Samarkos, G. L. Daikos, N. V. Sipsas on behalf of the REVERSE study group, “Active surveillance for hospital-acquired infections due to multidrug-resistant organisms in a hospital of a high-prevalence area, during the Omicron wave”, in the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2023, April 2023.                                                                                                                            
• Antonios Markogiannakis, Maria Gamaletsou, Athanasios Kakasis, Antonis Analitis, Ioannis Deliolanis, Aggeliki Pantazatou, Nikolaos Sipsas, “The impact of the COVID-19 pandemic on the antibiotic consumption and on the bloodstream infections caused by multidrug-resistant bacteria in a tertiary Greek hospital” in the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2022, April 2022.
• Nikolaos Zapaniotis, Athanasios Kakasis, Aggeliki Pantazatou, Ioannis Deliolanis, Nikolaos Sipsas, Maria Gamaletsou, “The impact of the COVID-19 pandemic on the frequency of candidemia in a tertiary care Greek hospital” in Trends In Medical Mycology (TIMM) 2021, October 2021.
• Antonios Markogiannakis, Athanasios Kakasis, Nikolaos Pantazis, Nikolaos Sipsas, Maria Gamaletsou, “The impact of the COVID-19 pandemic on the consumption of antifungals in a tertiary greek hospital”, in Trends In Medical Mycology (TIMM) 2021, October 2021.
• Maria Gamaletsou, Vasso Georgakopoulou, Antonios Markogiannakis,Dimitris Basoulis, Angeliki Tsifi, Athanasios Kakasis, Nikolaos Sipsas,”Isavuconazole for the treatment of patients with possible coronavirus disease-associated aspegillosis (CAPA): a single-center matched case-control study” in Trends In Medical Mycology (TIMM) 2021, October 2021.
• Poulakou G, Rapti V, Leontis K, Mousouli A, Kakasis A, Pagoni S, Tsimbos I, Masgala A,Simbardi S , Apostolopoulos V, Giannopoulos C, Alexiou N, Arvaniti K, Trakatelli C, PrionasA, Samarkos M, Tsiodras S, E. Giamarellou, “Assessment of de-escalation of empirical antimicrobial therapy in medical wards with high rates of multi-drug resistant bacteria: a multicenter prospective cohort study” in European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2020.

• Παθολογικό

Ευρωκλινική Αθηνών

Σούτσου 41 (Ισόγειο),  Αθήνα, ΤΚ 115 21

Τηλέφωνο: 6978064555

Email: akakasis@euroclinic.gr